Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors

<p><strong>Background:</strong> Insulin-like growth factors (IGFs) are known to play important roles in cancer biology, prompting evaluation of drugs targeting type 1 IGF receptor (IGF-1R). However, there is considerable lack of consensus in immunohistochemical (IHC) studies of IGF...

Full description

Bibliographic Details
Main Authors: Macaulay, V, Aleksic, T, Turley, H, Worrall, A, Verrill, C, Campo, L
Format: Journal article
Published: OMICS International Journals 2016
_version_ 1797082452500414464
author Macaulay, V
Aleksic, T
Turley, H
Worrall, A
Verrill, C
Campo, L
author_facet Macaulay, V
Aleksic, T
Turley, H
Worrall, A
Verrill, C
Campo, L
author_sort Macaulay, V
collection OXFORD
description <p><strong>Background:</strong> Insulin-like growth factors (IGFs) are known to play important roles in cancer biology, prompting evaluation of drugs targeting type 1 IGF receptor (IGF-1R). However, there is considerable lack of consensus in immunohistochemical (IHC) studies of IGF-1R in human tumors, confounding attempts to assess the predictive and prognostic significance of IGF-1R expression and subcellular localization. Likely sources of variation include use of different IGF-1R polyclonal antibodies and methods for IHC. Here, we aimed to develop a robust IGF-1R IHC protocol using a monoclonal antibody, suitable for use in formalin-fixed paraffin-embedded (FFPE) tissues.</p> <p><strong>Methods:</strong> Using controls including samples of FFPE tissues and tumor cells of defined IGF-1R expression, we used IHC and western blotting to compare polyclonal antibody #3027 with monoclonals #9750 and #14534 (Cell Signaling Technology).</p> <p><strong>Results:</strong> Compared with #3027, the monoclonals exhibited superior discrimination between IGF-1R-high and IGF-1R-deficient cells in manual IHC, signal generated by #9750 reflecting differences in IGF-1R expression detected by western blotting. In tissues, IGF-1R detected by #14534 was predominantly plasma membrane-associated, while #9750 detected IGF-1R in the plasma membranes, cytoplasm and nucleus of prostate and renal cancers, recapitulating appearances we described using previous lots of #3027, and reflecting subcellular localizations reported using other techniques. Use of #9750 and #14534 in an autostainer showed adequate differentiation of high vs low IGF-1R cells, but did not recapitulate appearances of manually-stained tissues. We provide a detailed protocol for the preferred manual method using #9750.</p> <p><strong>Conclusion:</strong> Standardization of IGF-1R IHC will promote understanding of the role of IGF-1R in tumor biology, and its potential as a candidate prognostic and predictive biomarker.</p>
first_indexed 2024-03-07T01:28:18Z
format Journal article
id oxford-uuid:92b7d9e8-c87e-4834-be0d-e9b63bbb0b4c
institution University of Oxford
last_indexed 2024-03-07T01:28:18Z
publishDate 2016
publisher OMICS International Journals
record_format dspace
spelling oxford-uuid:92b7d9e8-c87e-4834-be0d-e9b63bbb0b4c2022-03-26T23:27:31ZImproved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumorsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:92b7d9e8-c87e-4834-be0d-e9b63bbb0b4cSymplectic Elements at OxfordOMICS International Journals2016Macaulay, VAleksic, TTurley, HWorrall, AVerrill, CCampo, L<p><strong>Background:</strong> Insulin-like growth factors (IGFs) are known to play important roles in cancer biology, prompting evaluation of drugs targeting type 1 IGF receptor (IGF-1R). However, there is considerable lack of consensus in immunohistochemical (IHC) studies of IGF-1R in human tumors, confounding attempts to assess the predictive and prognostic significance of IGF-1R expression and subcellular localization. Likely sources of variation include use of different IGF-1R polyclonal antibodies and methods for IHC. Here, we aimed to develop a robust IGF-1R IHC protocol using a monoclonal antibody, suitable for use in formalin-fixed paraffin-embedded (FFPE) tissues.</p> <p><strong>Methods:</strong> Using controls including samples of FFPE tissues and tumor cells of defined IGF-1R expression, we used IHC and western blotting to compare polyclonal antibody #3027 with monoclonals #9750 and #14534 (Cell Signaling Technology).</p> <p><strong>Results:</strong> Compared with #3027, the monoclonals exhibited superior discrimination between IGF-1R-high and IGF-1R-deficient cells in manual IHC, signal generated by #9750 reflecting differences in IGF-1R expression detected by western blotting. In tissues, IGF-1R detected by #14534 was predominantly plasma membrane-associated, while #9750 detected IGF-1R in the plasma membranes, cytoplasm and nucleus of prostate and renal cancers, recapitulating appearances we described using previous lots of #3027, and reflecting subcellular localizations reported using other techniques. Use of #9750 and #14534 in an autostainer showed adequate differentiation of high vs low IGF-1R cells, but did not recapitulate appearances of manually-stained tissues. We provide a detailed protocol for the preferred manual method using #9750.</p> <p><strong>Conclusion:</strong> Standardization of IGF-1R IHC will promote understanding of the role of IGF-1R in tumor biology, and its potential as a candidate prognostic and predictive biomarker.</p>
spellingShingle Macaulay, V
Aleksic, T
Turley, H
Worrall, A
Verrill, C
Campo, L
Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title_full Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title_fullStr Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title_full_unstemmed Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title_short Improved immunohistochemical detection of type 1 insulin-Like growth factor receptor in human tumors
title_sort improved immunohistochemical detection of type 1 insulin like growth factor receptor in human tumors
work_keys_str_mv AT macaulayv improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors
AT aleksict improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors
AT turleyh improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors
AT worralla improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors
AT verrillc improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors
AT campol improvedimmunohistochemicaldetectionoftype1insulinlikegrowthfactorreceptorinhumantumors